We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
-1.56%
1 Year Est. Return
+29.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.45B
AUM Growth
-$851M
Cap. Flow
-$617M
Cap. Flow %
-9.57%
Top 10 Hldgs %
23.85%
Holding
3,274
New
30
Increased
484
Reduced
2,296
Closed
55

Top Sells

Rank Stock Value
1
RJF icon
Raymond James Financial
RJF
+$97M
2
HSY icon
Hershey
HSY
+$93.2M
3
MCHP icon
Microchip Technology
MCHP
+$92.3M
4
GPN icon
Global Payments
GPN
+$29.9M
5
MRK icon
Merck
MRK
+$29.2M

Sector Composition

Rank Sector Weight
1 Technology 21.55%
2 Financials 17.86%
3 Healthcare 13.05%
4 Industrials 9.07%
5 Consumer Discretionary 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGEN
2876
Agenus
AGEN
$322M
$533 ﹤0.01%
354
-268
-43% -$772
SBGI icon
2877
Sinclair Inc
SBGI
$1.02B
$526 ﹤0.01%
33
NABL icon
2878
N-able
NABL
$761M
$525 ﹤0.01%
74
EAF icon
2879
GrafTech
EAF
$186M
$520 ﹤0.01%
60
-32
-35% -$416
DFTX
2880
Definium Therapeutics
DFTX
$4.95B
$509 ﹤0.01%
87
+13
+18% +$93
NNOX icon
2881
Nano X Imaging
NNOX
$54M
$509 ﹤0.01%
102
+40
+65% +$277
ANAB icon
2882
AnaptysBio
ANAB
$1.62B
$502 ﹤0.01%
27
+7
+35% +$117
EB
2883
DELISTED
Eventbrite
EB
$498 ﹤0.01%
236
-153
-39% -$459
IMNM icon
2884
Immunome
IMNM
$2.72B
$498 ﹤0.01%
74
+21
+40% +$201
KURA icon
2885
Kura Oncology
KURA
$1.01B
$495 ﹤0.01%
75
IE icon
2886
Ivanhoe Electric
IE
$1.48B
$494 ﹤0.01%
85
AGS
2887
DELISTED
PlayAGS
AGS
$484 ﹤0.01%
40
BATRA icon
2888
Atlanta Braves Holdings Series A
BATRA
$3.59B
$483 ﹤0.01%
11
TELO icon
2889
Telomir Pharmaceuticals
TELO
$80.5M
$478 ﹤0.01%
148
-121
-45% -$529
CATX icon
2890
Perspective Therapeutics
CATX
$312M
$475 ﹤0.01%
223
-168
-43% -$504
ARTV
2891
Artiva Biotherapeutics
ARTV
$436M
$474 ﹤0.01%
158
-58
-27% -$313
KALV
2892
DELISTED
KalVista Pharmaceuticals
KALV
$473 ﹤0.01%
41
IRMD icon
2893
iRadimed
IRMD
$1.05B
$472 ﹤0.01%
9
ONT
2894
Onterris Inc
ONT
$625M
$471 ﹤0.01%
33
SKYE icon
2895
Skye Bioscience
SKYE
$9.34M
$464 ﹤0.01%
37
-25
-40% -$546
ARVN icon
2896
Arvinas
ARVN
$540M
$463 ﹤0.01%
66
CRBP icon
2897
Corbus Pharmaceuticals
CRBP
$134M
$457 ﹤0.01%
86
-58
-40% -$512
MYE icon
2898
Myers Industries
MYE
$1.12B
$453 ﹤0.01%
38
STKL
2899
DELISTED
SunOpta
STKL
$452 ﹤0.01%
93
AMBP icon
2900
Ardagh Metal Packaging
AMBP
$2.87B
$450 ﹤0.01%
149

Similar funds

Sterling Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Sterling Capital Management held 3,274 positions worth $6.45B, down 12% from $7.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Sterling Capital Management withdrew a net $617M in Q1 2025, closing 55 positions and reducing 2,296 holdings. Its most notable exit was WESCO International, Inc. Depositary Shares each representing 1/1,000th interest in a share of Series A Fixed-Rate Reset Cumulative Perpetual Preferred Stock, an estimated $4.77M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Sterling Capital Management opened a new position in Samsara worth $2.79M.

  • Sterling Capital Management's largest Q1 2025 buy was Samsara: 72,827 shares worth $2.79M.
  • Sterling Capital Management added most to Linde in Q1 2025, an estimated $102M increase.
  • Sterling Capital Management's biggest Q1 2025 reduction was Raymond James Financial, cutting an estimated $97M.
  • Sterling Capital Management fully exited WESCO International, Inc. Depositary Shares each representing 1/1,000th interest in a share of Series A Fixed-Rate Reset Cumulative Perpetual Preferred Stock in Q1 2025, selling an estimated $4.77M.
  • Sterling Capital Management's ten largest holdings make up 24% of its $6.45B portfolio in Q1 2025.
  • Sterling Capital Management opened 30 new positions and closed 55 in Q1 2025.
  • Sterling Capital Management's portfolio value fell 12% quarter-over-quarter to $6.45B.

Based on Sterling Capital Management's 13F filing for Q1 2025, filed 13 May 2025.